Skip to content
1 Minute Read

CRIO Joins Forces with the Association of Diversity in Clinical Trials as a Supporting Partner to Drive Inclusive Research Advancements

CRIO Joins Forces with the Association of Diversity in Clinical Trials as a Supporting Partner to Drive Inclusive Research Advancements

DALLASAug. 14, 2023  – The Association of Diversity in Clinical Trials (AOD) and CRIO, a leading eSource technology provider, are excited to announce a new partnership. CRIO’s software platform empowers research sites to run more effectively, enabling research in underserved communities. CRIO’s work aligns with AOD’s mission to establish standards and best practices for the clinical trials industry to improve the representation of diverse participants in clinical trials through the development, integration, and monitoring of quality and consistent diversity methodology across the research industry.

By joining the AOD as a Supporting partner, CRIO and CEO Raymond Nomizu, continue their commitment to being an ally in the improvement of Diversity in clinical trials. “CRIO enables the start-up of new sites and investigators, enabling research in previously underserved communities, “says Raymond Nomizu, CEO at CRIO. “CRIO supports the mission of Association of Diversity and looks forward to collaborating with other industry stakeholders to advance the mission.”

Dr. Diana Foster, AOD’s CEO, highlighted the vital role of technology and CRIO in advancing their mission. Dr. Foster explains “Technology-driven methods cut costs, expedite trials, and aid personalized treatments, ultimately accelerating safer therapies to patients. CRIO’s innovation in the technology sector remains evident.” The AOD’s collaborative efforts aim to reshape clinical trial diversity in the industry.

About The Association of Diversity in Clinical Trials
The AOD is comprised of partners who are committed to developing evidence-based approaches including, consultive advisement, consolidation of the understanding of diversity challenges: report, and the development of standards for best practices at the site and sponsor level. For information about The Association of Diversity in Clinical Trials and to view the partnership levels, visit our website at

About CRIO
CRIO is a health tech company helping pharma, biotech, research sites, and academic research centers streamline regulatory workflows with one system that enables a single point of data capture. As the leader in eSource technology, CRIO enables remote monitoring and immediate data review with a powerfully integrated eSource/EDC solution. CRIO’s mission is to design and deliver a modern, intuitive, and integrated software platform that reimagines clinical trials for quality, speed, and patient-centricity.


SOURCE The Association of Diversity in Clinical Trials

CRIO favicon by Team CRIO
Share this post
You may also find interesting
Explore our Blog
Algorics Partnership
CRIO Company News
1 Minute Read -

CRIO Announces Partnership with Algorics

CRIO is thrilled to announce an exciting partnership with Algorics! This partnership represents our continued efforts in revolutionizing the landscape of clinical trials technology. At CRIO, our commitment has always been to provide innovative solutions that drive data quality and enhance patient safety, while saving CRIO sites and sponsors both time and money. “CRIO is...

CRIO and SDC Partnership
CRIO Company News
2 Minute Read -

SDC Announces Partnership with CRIO on eSource Initiative

Boston, MA – Continuing the momentum of technology solution innovations after its recent release of SDC Insights™, SDC is proud to partner with CRIO to bring eSource functionality in-house to better serve clients and their clinical needs.  “With SDC’s in-house developers, we can efficiently meet the individual needs of each protocol with CRIO eSource, a...

Our new board of directors member Jeff Stein
CRIO Company News
1 Minute Read -

We are pleased to announce Mr. Jeffrey Stein as the newest member of CRIO’s Board of Directors!

Jeff Stein currently serves as the CEO and President of ALSA Research, which has been an early adopter of cloud-based technologies that are now standard practices across the clinical research industry. After beginning his career on Wall Street with Salomon Brothers, Jeff opened the firm’s London based MBS group. Shortly after, Jeff acquired a controlling...

Get articles delivered to your inbox, every week